Back to TCRX
MARSHALL WACE, LLP TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
16
Latest value
$82K
Q3 2026
Peak value
$1.8M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $42K |
| Q4 2023 | $603K |
| Q1 2024 | $1.5M |
| Q2 2024 | $1.8M |
| Q3 2024 | $13K |
| Q3 2024 | $810K |
| Q4 2024 | $134K |
| Q2 2025 | $37K |
| Q2 2025 | $40K |
| Q3 2025 | $4K |
| Q3 2025 | $81K |
| Q4 2025 | $21K |
| Q4 2025 | $318K |
| Q2 2026 | $674K |
| Q3 2026 | $1K |
| Q3 2026 | $82K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $82K | 265.3K | — | — |
| Q3 2026 | $1K | 4.3K | — | — |
| Q2 2026 | $674K | 687.4K | — | — |
| Q4 2025 | $318K | 318.3K | — | — |
| Q4 2025 | $21K | 21.0K | — | — |
| Q3 2025 | $81K | 44.3K | — | — |
| Q3 2025 | $4K | 2.3K | — | — |
| Q2 2025 | $40K | 27.9K | — | — |
| Q2 2025 | $37K | 25.8K | — | — |
| Q4 2024 | $134K | 44.0K | — | — |
| Q3 2024 | $810K | 162.6K | — | — |
| Q3 2024 | $13K | 2.6K | — | — |
| Q2 2024 | $1.8M | 307.5K | — | — |
| Q1 2024 | $1.5M | 191.2K | — | — |
| Q4 2023 | $603K | 103.4K | — | — |
| Q4 2023 | $42K | 7.1K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M